1. Report Introduction
2. Exocrine Pancreatic Insufficiency Epidemiology Overview at a Glance
3. Market Share Distribution of Exocrine Pancreatic Insufficiency
4. Disease Background and Overview: Exocrine Pancreatic Insufficiency
4.1. Introduction
4.2. Signs and Symptoms
4.3. Etiology
4.4. Risk Factors
4.5. Pathophysiology
4.6. Diagnostic Landscape
4.6.1. Diagnostic Practices
4.6.2. Diagnostic Criteria
4.6.3. Diagnostic Recommendations
4.7. Treatment Landscape
4.7.1. Current Treatment Practices
4.7.2. Treatment Algorithm
4.7.3. Treatment Recommendations
5. Exocrine Pancreatic Insufficiency Epidemiology
5.1. Key Findings
5.2. Assumptions & Rationale
5.3. 7MM Epidemiology
6. Epidemiology of Exocrine Pancreatic Insufficiency by Countries
7. United States
7.1. Assumptions and Rationale
7.2. Prevalent/Incident Cases of Exocrine Pancreatic Insufficiency
7.3. Sub-Type Specific cases of Exocrine Pancreatic Insufficiency*
7.4. Sex- Specific Cases of Exocrine Pancreatic Insufficiency*
7.5. Diagnosed Cases of Exocrine Pancreatic Insufficiency
7.6. Treated Cases of Exocrine Pancreatic Insufficiency
8. EU5
8.1. Germany
8.1.1. Assumptions and Rationale
8.1.2. Prevalent/Incident Cases of Exocrine Pancreatic Insufficiency
8.1.3. Sub-Type Specific cases of Exocrine Pancreatic Insufficiency*
8.1.4. Sex- Specific Cases of Exocrine Pancreatic Insufficiency*
8.1.5. Diagnosed Cases of Exocrine Pancreatic Insufficiency
8.1.6. Treated Cases of Exocrine Pancreatic Insufficiency
8.2. France
8.2.1. Assumptions and Rationale
8.2.2. Prevalent/Incident Cases of Exocrine Pancreatic Insufficiency
8.2.3. Sub-Type Specific cases of Exocrine Pancreatic Insufficiency*
8.2.4. Sex- Specific Cases of Exocrine Pancreatic Insufficiency*
8.2.5. Diagnosed Cases of Exocrine Pancreatic Insufficiency
8.2.6. Treated Cases of Exocrine Pancreatic Insufficiency
8.3. United Kingdom
8.3.1. Assumptions and Rationale
8.3.2. Prevalent/Incident Cases of Exocrine Pancreatic Insufficiency
8.3.3. Sub-Type Specific cases of Exocrine Pancreatic Insufficiency*
8.3.4. Sex- Specific Cases of Exocrine Pancreatic Insufficiency*
8.3.5. Diagnosed Cases of Exocrine Pancreatic Insufficiency
8.3.6. Treated Cases of Exocrine Pancreatic Insufficiency
8.4. Spain
8.4.1. Assumptions and Rationale
8.4.2. Prevalent/Incident Cases of Exocrine Pancreatic Insufficiency
8.4.3. Sub-Type Specific cases of Exocrine Pancreatic Insufficiency*
8.4.4. Sex- Specific Cases of Exocrine Pancreatic Insufficiency*
8.4.5. Diagnosed Cases of Exocrine Pancreatic Insufficiency
8.4.6. Treated Cases of Exocrine Pancreatic Insufficiency
8.5. Italy
8.5.1. Assumptions and Rationale
8.5.2. Prevalent/Incident Cases of Exocrine Pancreatic Insufficiency
8.5.3. Sub-Type Specific cases of Exocrine Pancreatic Insufficiency*
8.5.4. Sex- Specific Cases of Exocrine Pancreatic Insufficiency*
8.5.5. Diagnosed Cases of Exocrine Pancreatic Insufficiency
8.5.6. Treated Cases of Exocrine Pancreatic Insufficiency
9. Japan
9.1. Assumptions and Rationale
9.2. Prevalent/Incident Cases of Exocrine Pancreatic Insufficiency
9.3. Sub-Type Specific cases of Exocrine Pancreatic Insufficiency*
9.4. Sex- Specific Cases of Exocrine Pancreatic Insufficiency*
9.5. Diagnosed Cases of Exocrine Pancreatic Insufficiency
9.6. Treated Cases of Exocrine Pancreatic Insufficiency
10. Unmet Needs
Appendix
Report Methodology
Sources Used
Disclaimer
About CmaxInsight
*Indication Specific

Note: Certain sections of the table of contents would vary according to the availability of information.